Artivion, Inc. (FRA:CYL)

Market Cap	1.56B +22.1%
Revenue (ttm)	375.88M +13.6%
Net Income	8.31M
EPS	0.18
Shares Out	n/a
PE Ratio	187.47
Forward PE	45.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	32.25
Previous Close	31.70
Day's Range	32.25 - 32.30
52-Week Range	19.44 - 41.10
Beta	n/a
RSI	39.84
Earnings Date	Feb 12, 2026

About Artivion

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branc...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1984
• Employees: 1,800
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CYL

Financial Performance

Financial numbers in USD